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Abstract.  Polyclonal antibodies directed against 
ribophorins I and II, two membrane glycoproteins 
characteristic of the rough endoplasmic reticulum, in- 
hibit the cotranslational translocation of a  secretory 
protein growth hormone into the lumen of dog pan- 
creas or rat liver microsomes. As expected, site- 
specific antibodies to epitopes located within the cyto- 
plasmic domain of ribophorin I, but not antibodies to 
epitopes in the luminal domain of this protein, were 
effective in inhibiting translocation. Since monovalent 
Fab fragments were as inhibitory as intact IgG mole- 
cules, ribophorins must be closely associated with the 
translocation site and, therefore, are likely to function 
at some stage in the translocation process.  In all 
cases, the antibodies that inhibited translocation also 
caused a  significant reduction in total protein synthesis 
and treatments that neutralized their capacity to inhibit 
translocation also prevented their inhibitory effect on 
protein synthesis. This would be expected if the anti- 
bodies blocked the membrane-mediated relief of the 
SRP-induced arrest of polypeptide elongation. The an- 
tibodies were effective only when added before trans- 
location was allowed to begin.  In this case, they 
prevented the targeting of active ribosomes containing 
mRNA and nascent chains to the ER membrane. 
Thus, ribophorins must either directly participate in 
targeting or be so close to the targeting site that the 
antibodies sterically blocked this early phase of the 
translocation process. 
I 
N the rough ER of higher eukaryotic cells, a complex mo- 
lecular apparatus effects the signal sequence-mediated 
targeting, cotranslational translocation, and processing 
of nascent polypeptide chains that are synthesized on mem- 
brane bound ribosomes (for reviews  see Rapaport,  1986; 
Walter and Lingappa,  1986;  Sabatini and Adesnik,  1989). 
The targeting step begins in the cytosol when a large ribonu- 
cleoprotein complex, the signal recognition particle (SRP), 
binds  to  the  ribosome and to  the  signal  sequence  in the 
emerging nascent polypeptide (Walter et al.,  1981; Walter 
and Blobel,  1981). Subsequent steps take place in associa- 
tion with the ER membrane and, in recent years, several poly- 
peptides characteristic of these membranes have been iden- 
tified that appear to participate in the membrane insertion 
and processing of the nascent polypeptide. These include: 
(a) two subunit polypeptides of an SRP receptor or docking 
protein, that recognizes the SRP (Meyer and Dobberstein, 
1980a,b; Lauffer et al., 1985; Tajima et al., 1986; Connolly 
and Gilmore, 1989); (b) a putative signal sequence receptor 
(SSR),  which is a  35-kD  integral membrane glycoprotein 
that can be cross-linked to the signal sequence and to other 
portions of the nascent chain during the course of transloca- 
1.  Abbreviations used in  this paper:  GH,  growth hormone; RM,  rough 
microsome; RI and RII, ribophorins I and II; SRP, signal recognition parti- 
cle; SSR, signal sequence receptor. 
tion (Wiedmann et al.,  1987; Hartmann et al.,  1989; Krieg 
et al.,  1989);  (c) a complex of six polypeptide chains that 
manifests signal peptidase activity (Evans et al., 1986); and 
(d) two glycoproteins, known as ribophorins I and II (RI and 
RII) that are in close proximity to the bound ribosomes (Krei- 
bich et al.,  1978a,b;  Kreibich et al.,  1983).  Although the 
SRP receptor plays an important role in targeting ribosomes 
containing nascent chains with appropriate signal sequences 
to the ER membrane, it does not appear to participate in sub- 
sequent stages of translocation, since it is present in amounts 
substantially lower than the number of ribosomes bound to 
the membrane (Tajima et al., 1986). The other polypeptides, 
however, are present in higher amounts and, in some cases, 
in approximately stoichiometric amounts with respect to the 
number  of membrane bound ribosomes  (Kreibich et al., 
1978a,b; Marcantonio et al., 1984; Evans et al., 1986; Hart- 
man et al., 1989). These could, therefore, be permanent com- 
ponents of the translocation apparatus. In fact, it has recently 
been shown that antibodies to the SSR abolish the capacity 
of microsomal membranes to translocate nascent polypep- 
tides in an in vitro system (Hartmann et al.,  1989). 
Direct evidence for the participation of RI and RII in the 
translocation process has not yet been reported. These pro- 
teins, which have no sequence homology, both have a simple 
transmembrane disposition with large amino terminal lumi- 
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terminal segments of 150 and 70 amino acids, respectively 
(Crimaudo et al., 1987; Harnik-Ort et al., 1987). They, and 
a limited number of other membrane polypeptides, can be 
recovered with ribosomes when these are sedimented after 
the microsomal membranes are dissolved with certain non- 
ionic detergents. In this case, a membrane remnant is ob- 
tained in which the residual proteins appear to form a two- 
dimensional  network bearing  ribosomes  (Kreibich et al., 
1978a).  On  this  basis,  it  was  proposed  (Kreibich et al., 
1978a,b) that the ribophorins play a  structural role in the 
ER, providing a scaffolding within the membranes that re- 
stricts the ribosome binding sites and their associated trans- 
location apparatus to the rough portions of the organelle. 
Ribophorins are sufficiently close to the membrane bound 
ribosomes that, in intact microsomes, can be cross-linked to 
them with bifunctional reagents (Kreibich et al.,  1978b). It 
appears, however, that ribophorins are not directly involved 
in ribosome binding since the capacity of microsomal mem- 
branes stripped of ribosomes to rebind ribosomes in vitro, 
in an association that involves a salt sensitive linkage and is 
independent of the presence of a nascent chain (Borgese et 
al., 1974; Amar-Costesec et al., 1984), can be abolished by 
mild treatment of the membranes with proteases, which does 
not degrade the ribophorins (Hortsch et al.,  1986). More- 
over, liposomes containing microsomal phospholipids and 
only the nonglycoprotein components of rough microsomes 
have been shown to be capable of binding ribosomes under 
the same conditions (Yoshida  et al.,  1987). 
In this paper, evidence is presented that the ribophorins 
are, indeed, functionally involved in the sequence of events 
that leads to protein translocation in the ER. It was found that 
incubation of rough microsomes with antibodies to either 
ribophorin I or II abolished the capacity of the membranes 
to effect the cotranslational translocation of an indicator pro- 
tein, rat growth hormone (GH). Antibodies to sites in the cy- 
toplasmic domain, but not antibodies to sites in the luminal 
domain of ribophorin I, were inhibitory. In addition, anti- 
ribophorin I antibodies were only effective when applied be- 
fore translocation was initiated. This suggests that ribopho- 
rin I either plays a role in the initial stages of this process 
or is closely apposed to another component of the transloca- 
tion apparatus that participates in the attachment of active 
ribosomes to the translocation site. 
Materials and Methods 
Preparation of  Antibodies 
Polyclonal antibodies were raised against SDS-PAGE-purified RI and RII 
(Marcantonio et al.,  1984) or against synthetic peptides corresponding to 
specific  RI  sequences.  These  included  RILl  (aa  234-252),  RIL2  (aa 
351-364),  RICI  (aa 434-454),  RIC2  (aa 455-476),  RIC3  (aa 477-494), 
RICa (aa 511-531),  RIC5 (aa 529-548), and RIC6 (aa 564-583).  The syn- 
thetic peptides, coupled to keyhole limpet hemocyanin with glutaraldehyde, 
were used to immunize rabbits (for details, see Frey et al., 1985).  Monoclo- 
nal antibodies were raised against SDS-denatured RI by standard proce- 
dures (de St. Groth and Scheidegger, 1980;  Croze et al.,  1989). 
Antibodies against ribophorins or cytochrome P450 2c (Waxman et al., 
1984)  were affinity  purified essentially as  described by  Wollner et  al. 
(1986).  Dog  pancreas or rat  liver microsomal proteins fractionated by 
preparative SDS-PAGE were electrophoretically transferred onto nitrocellu- 
lose paper. Strips corresponding to the desired antigens were cut out and 
used as an affinity matrix to purify specific antibodies. The eluted antibod- 
ies were concentrated in a Centricon-30 microconcentrator (Amicon Corp., 
Danvers, MA), while replacing the buffer with PBS. To avoid losses during 
the concentration step, albumin or gelatin (the latter only when specifically 
stated) was added (final concentration 2.5 mg protein/ml). Fab fragments 
from a total IgG fraction of anti-RIC6 were prepared using an ImmunoPure 
kit from Pierce Chemical Co. (Rockford, IL) and were concentrated in the 
Amicon Corp. apparatus while replacing the buffer with PBS. 
Inhibition of  Protein Translocation by Anti-RI and 
Anti-RH Antibodies 
Dog pancreas rough microsomes and SRP (Walter  and Blobel,  1983a,b), 
rat liver rough microsomes (Kruppa and Sabatini, 1977) and red blood cell 
ghosts (Steck and Kant, 1974) were prepared according to published proce- 
dures. Cell-free translation using in vitro synthesized mRNA was carried 
out as previously described (Harnik-Ort et al., 1987). A plasmid containing 
a rat GH cDNA insert was used to generate the mRNA template (Rizzolo 
et al., 1985). For cotranslational translocation, 30 #1 of a wheat germ trans- 
lation mixture was supplemented with rough microsomes (10/~g  protein), 
20 nM SRP and 0.002 % Nikkol, and incubated for 1.5 h at 25°C. Transloca- 
tion efficiency was assessed by digestion of the samples (1 h; 0°C) with a 
mixture of trypsin and chymotrypsin (100 t~g/ml each). In most cases, the 
processed GH was not quantitatively protected from proteolysis; this may 
be due to the fragility of the microsomes or that the rather high concentra- 
tions of proteases required for complete digestion of preGH affected the in- 
tegrity of the microsomal vesicles. 
IgG fractions (preheated to 65°C for 10 rain), affinity-purified antibod- 
ies, or monovalent Fab fragments were all prepared in PBS (20 mM phos- 
phate, 145 mM NaCI, pH 7.5) and, for antibody inhibition experiments, ad- 
justed to concentrations that were all equally reactive in a Western blot test 
in which the immobilized antigens were present in large excess. 
For each antibody inhibition assay, the antibody preparation ('~0.75  mg 
for the IgG fractions or Fab fragments, or 3 #g affinity-purified IgG)  was 
mixed with 30 #1 of a mixture of protease inhibitors (0.1% trasylol, and 0.1 
tzg/ml each of chymostatin, leu-leu-leu, leupeptin, pepstatin, and antipain) 
in PBS and incubated at room temperature for 15 rain. Dog pancreas (6/~g 
protein) or rat liver (10 #g protein) rough microsomes (RMs) were then 
added, and incubation was continued with gentle shaking at room tempera- 
ture for 0.5 h followed by 0.5 h at 4°C. The microsomes, to a great extent 
stripped of ribosomes during the incubation with the PBS-containing incu- 
bation medium, were recovered by centrifugation for 0.5  h  at 4°C in a 
microcentrifuge  (model  235B;  Fisher  Scientific  Co.,  Pittsburgh,  PA), 
rinsed with washing buffer containing 20 mM Hepes (pH 7.4), 50 mM KAc 
and  1 mM MgAC2,  and resuspended in 30/zl of a wheat germ cell-free 
translation mixture. When testing their capacity to neutralize the antibody 
inhibitory effect, the peptides were mixed with the antibodies and incubated 
for 0.5 h at 37°C (or 10 min at 65°C) in a water bath, and then for 0.5 h 
at room temperature before adding to the microsomes. The amount of pep- 
tide used (1.2/~g) was approximately in a 500-fold molar excess with respect 
to the amount of RI in the RM. 
In control experiments, antibodies were preadsorbed with  Sepharose 
beads,  protein A-Sepharose beads,  puromycin/high  salt  stripped  rough 
microsomes, or red blood cell ghosts, and, after centrifugation, the flow- 
through fractions or supernatants were used to treat the microsomes. 
The intensities of the preGH and GH bands in the autoradiograms were 
determined using a scanning densitometer (GS 300;  Hoefer Scientific In- 
struments, San Francisco, CA). The numbers corresponding to the intensi- 
ties of the GH bands were multiplied by seven-sixths to correct for the loss 
of the Met residue in the signal sequence. 
Assays for the Effect of the Antibody at Different 
Stages of  Protein Translocation 
Preincubation of RM with Antibodies. Dog pancreas RMs preincubated 
with or without affinity-purified antibodies were recovered by centrifugation 
and incubated at 25°C for 3 min in a GH mRNA-programmed wheat germ 
translation mixture containing 20 nM SRP and 0.002% Nikkol. Translation 
was stopped by cooling on ice, and supernatant and RM pellet fractions 
were separated by centrifugation for 30 rain in a microcentrifuge (Fisher 
Scientific Co.) at 4°C. To determine the extent to which translation initia- 
tion had taken place, the supernatant was divided into two equal parts. One 
was directly analyzed by SDS-PAGE, to confirm that no complete preGH 
and/or GH had been made, and the second was incubated for 1.5 h at 25°C 
for further elongation of initiated chains in the presence of 5 mM initiation 
inhibitor 7mG(53p before SDS-PAGE. The RMs pellet fraction containing 
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incubation was rinsed twice and resuspended in a wheat germ translation 
mixture that contained the initiation inhibitor and no added mRNA. Elonga- 
tion was then allowed to proceed during incubation for 1.5 h at 25°C. 
Incubation  of RM with Antibodies after 3 min of Translation.  Dog 
pancreas RMs were added to a wheat germ translation mixture containing 
preGH mRNA, 20 nM SRP, 0.002%  Nikkol, and incubation at 25°C was 
carded out for 3 min, before cooling on ice and centrifugation, as described 
above. The supernatant was used to assess the extent of initiation, as just 
described, and the sedimented RMs were resuspended and incubated in 30 
ttl PBS with or without the affinity-purified antibodies. The RMs were again 
recovered by centrifugation, rinsed, and resuspended in the wheat germ 
elongation mixture containing the initiation inhibitor in which they were in- 
cubated for  1.5 h at 25°C. 
Results 
The Protein Translocation Capacity of  RMs Is 
Inhibited by Pretreatment with Polyclonal Antibodies 
against RI or RH 
The capacity of RMs to effect cotranslational translocation 
was  assessed  in  translation  systems programmed  with  in 
vitro synthesized rat GH messenger RNA.  GH serves as a 
convenient  indicator  protein  to  assess  translocation  since 
preGH, synthesized in the absence of RMs, is easily distin- 
guished by its electrophoretic mobility (Mr  =  25 kD) from 
mature GH (Mr  =  22  kD)  that has undergone  removal of 
the signal (Fig.  1, compare lanes a and b or g and h). Trans- 
location of the signal-cleaved product into the microsomal 
lumen can be easily assessed from its resistance to the attack 
of added proteases (Fig. 1, lanes a'-l'), which completely di- 
gest any untranslocated preGH molecules found in the same 
samples. 
As shown in Fig. 1 (lanes c and e, c' and e'), preincubation 
with anti-RI or anti-RII IgGs inhibits the translocation com- 
petence of the microsomes by 67 % (Fig.  1, lane c) and 78 % 
(Fig.  1, lane e), respectively. On the other hand, the translo- 
cation  capacity  of RMs  preincubated  with  IgG  fractions 
from which antibodies had been removed by adsorption to 
protein A-Sepharose was unimpaired (<2 %; Fig.  1, lanes d, 
f, d', and f). This indicates that the inhibition of transloca- 
tion was caused by antibodies and  not by a  contaminating 
agent in the immunoglobulin fractions. The inhibitory activ- 
ity of the antibody preparations was also dramatically reduced 
when, before addition to the microsomes, the IgG samples 
were preincubated with excess amounts of RMs, which were 
then sedimented to remove the adsorbed antibodies (Fig.  1, 
lanesj and 1, j' and l'). The preadsorbed anti-RI and anti-RII 
antibodies caused only a 14 % and 3 % reduction in transloca- 
tion, respectively, as compared to the sample incubated with 
nonimmune IgG (Fig.  1, lane h).  In contrast, the inhibitory 
effect of the IgG fractions was unimpaired when red blood 
cell ghosts were used in the preadsorption step (Fig.  1, lane 
i and k, i' and k'), still giving 93%  (anti-RI) and 99% (anti- 
RII) inhibition. It can, therefore, be concluded that the inhi- 
bition of translocation observed was a specific effect caused 
by binding of antiribophorin antibodies to antigens exposed 
on the microsomal surface. It is noteworthy that only when 
the antibodies inhibited translocation did they cause a  sub- 
stantial  reduction  of growth hormone synthesis (preGH  + 
GH). This is consistent with the possibility that the inhibi- 
tion of translation is a consequence of the antibodies block- 
ing the membrane-mediated relief of the arrest of polypep- 
tide elongation caused by SRP. 
Figure 1. Antibodies against RI or against RII inhibit the transloca- 
tion activity of RM.  (A) In vitro synthesized rat GH mRNA was 
translated in a wheat germ cell-free system containing [35S]methi- 
onine, in the absence (lanes a and g) or presence (lanes b-f  and h-l) 
of dog pancreas  RMs  (6 #g protein).  The RMs had been prein- 
cubated in PBS with nonimmune (NI) IgG (lanes b and h), or with 
anti-RI  IgG or  anti-RII IgG that  had  been  preincubated  with 
Sepharose  beads  (S)  (lanes  c  and  e).  As controls,  anti-RI and 
anti-RII IgGs preincubated  with protein A-Sepharose beads (SA) 
(lanes d and f), red blood cell membranes (RC) (lanes i and k) or 
dog pancreas RMs (lanesj and l) were used. After protein synthe- 
sis, duplicate samples (lanes a'-l'),  were incubated with a mixture 
of trypsin/chymotrypsin  (100 #g/ml each) for 1 h at 0°C. All sam- 
ples were analyzed by SDS-PAGE (10-15% polyacrylamide)  and 
autoradiography (12 h). The results shown in lanes a-f  and g-l were 
obtained from two different experiments. (B) Quantitative analysis 
of the autoradiograms.  The intensity of the preGH and GH bands 
in the autoradiograms  in A were obtained by densitometry, as indi- 
cated in Materials and Methods. The numbers in each column are 
derived from the labeled lane with the same letter in A. The samples 
containing  nonimmune IgG (lanes b and h) serve as controls  for 
those in lanes c-f and i-l,  respectively. 
Arbitrary  numbers  corresponding  to  intensities  of the  bands 
measured by densitometry;  GH 
2 For each sample, this is expressed as preGH +  GH x  100; 
3 [ 1_  (transl°cati°n efficiency °f each sample c°ntaining membranes) I  xl00; 
(translocation  efficiency of the corresponding  control) 
4 [(preGH  +  GH)sample/(preGH +  GH)control]  x  100. 
Antibodies That Recognize the Cytoplasmic Domain of 
RI, but Not Those That Recognize the Luminal 
Domain, lnhibit Protein Translocation 
To confirm that the inhibitory effect of the antiribophorin an- 
tibodies was due to their interaction with cytoplasmically ex- 
posed portions of the  RI molecule,  site-specific antibodies 
were prepared against  synthetic peptides corresponding to 
segments within the cytoplasmic and luminal regions of RI 
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cytoplasmic or luminal domains  of ribophorin  I.  (A)  Schematic 
representation of the primary structure of mature rat RI (583  aa). 
The numbers refer to amino acid residues, the N-glycosylation site 
(aa 275) is labeled with an asterisk, and the transmembrane domain 
(415-433 aa) by the cross-hatched vertical bar. The positions of the 
luminal (L~, L2) and cytoplasmic (C1-C6) sequences used to gen- 
erate  site-specific  antibodies  are  indicated.  Titers  of antibodies 
against the peptides RICI, RIC2, and RIC3 were too low to obtain 
satisfactory Western blots.  These antibodies were,  therefore,  not 
used for any of the subsequent experiments. (B) Dog pancreas RMs 
(0.5 mg protein/ml) were either digested with a mixture of trypsin 
and chymotrypsin (100 #g/ml each; 0°C, 1 h) (lanes a-f) to gener- 
ate a protected fragment (RIe) corresponding to the luminal and 
transmembrane domains of RI, or kept undigested as controls (lanes 
a' tof'). The SDS solubilized microsomal protein samples (50 #g 
protein each) were then fractionated by SDS-PAGE and analyzed 
by immunoblotting with polyclonal anti-RI (lanes a  and a'), anti- 
RIC4 (lanes b and b'), anti-RIC5  (lanes c and c'), anti-RIC6  (lanes 
d  and d'),  anti-RIL2  (lanes  e  and e'), or a  monoclonal antibody 
against RI (MC) (lanes f  and f'). 
(Fig. 2 A). The specificity of these antibodies was confirmed 
by Western blot analysis using RMs that were either intact 
or had been previously incubated with a  mixture of trypsin 
and  chymotrypsin to digest the cytoplasmic portion  of RI. 
Antibodies to synthetic peptides corresponding  to the cyto- 
plasmic segments (RIC4, RICs, and RIC6) detected only in- 
tact RI (Fig. 2 B, lanes b, b', c', and d, d'), while antibodies 
to a  synthetic  peptide  corresponding  to a  luminal  segment 
(RIL2) detected both the intact RI (Fig.  2,  lane e') and the 
protected  fragment  (RIf)  generated  by proteolysis  (Fig.  2, 
lane e). An mAb that was raised against purified RI also rec- 
ognized both intact molecules (Fig.  2, lanef') and the frag- 
ments  that  lack  the  cytoplasmic  domain  (Fig.  2,  lane f). 
Thus,  this  antibody must be directed to an epitope located 
in either  the luminal  or the transmembrane  domain  of RI. 
The polyclonal anti-RI antibody used for the experiments in 
Fig.  1 that blocked protein translocation recognized the pro- 
tected  fragment (Fig.  2,  lane a)  much  less effectively than 
the  intact  molecule  (Fig.  2,  lane  a'),  which  indicates  that 
most of the antibody molecules in that preparation recognize 
cytoplasmic epitopes of RI. 
Figure 3. Only antibodies recognizing epitopes in the cytoplasmic 
domain  of ribophorin  I  inhibit  translocation.  (A)  Dog  pancreas 
RMs were preincubated with PBS (lanes a, h, i, and l) or with the 
specific Abs indicated on top of each lane, before they were added 
to a wheat germ translation mixture programmed with GH mRNA. 
For lanes k and  l,  the preincubation medium also contained the 
RIC6 peptide (C6).  Since the affinity-purified antibody prepara- 
tions used in the experiment shown in lanesj and k contained gela- 
tin,  this  carrier  protein  was  also  included  in  the  preincubation 
medium used for one of the controls (lane i). Note that addition of 
gelatin causes a 9%  inhibition of translocation (compare lanes h 
and i).  After translation,  duplicate samples were incubated with 
proteases, as in Fig.  1, to assess the extent of translocations of GH 
(lanes a' to l'). All samples were analyzed by SDS-PAGE and auto- 
radiography  (12  h).  (B)  Quantitative  analysis  of the  autoradio- 
grams. Footnotes  1-4 are defined in the legend to Fig.  1. 
* For this sample, the control that represents no inhibition of trans- 
location is lane h, instead of lane i, which is the control forj and k. 
When the different antibody preparations characterized by 
the immunoblot analysis of intact and proteolysed RMs were 
tested for their capacity to block translocation (Fig. 3), it was 
found that antibodies to synthetic peptides corresponding to 
different  segments  within  the  cytoplasmic  domain  of  RI 
(RIC4,  RICs,  RIC6;  Fig.  3,  lanes  c-e,  and  c'-e'),  showed 
similar inhibitory  effects on translocation  (62-97 %  reduc- 
tion)  as  the  polyclonal  antibody  (83%  reduction)  (Fig.  3, 
lanes b, b'). On the other hand, antibodies to the luminal do- 
main  of  RI,  such  as  anti-RIL2  and  the  mAb,  had  no 
significant inhibitory effect (Fig.  3, lanesfand  g, f  and g'; 
14 and  19%  inhibition,  respectively).  As expected,  the in- 
hibitory capacity of the afffinity-purified antipeptide antibod- 
ies was neutralized  when the corresponding  synthetic pep- 
tides were added to block the antibody binding site (compare 
Fig.  3,  lanes i, j,  and k, and i', j',  and k' for anti-RIC6).  In 
this experiment,  preincubation  with anti-RI6 caused a  93 % 
inhibition of translocation (Fig.  3, lane j) whereas the same 
antibody  neutralized  with  the  RIC6  peptide  caused  only 
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this experiment, too, all the antibodies that inhibited translo- 
cation (and only these) also reduced overall protein synthe- 
sis to 38-55%  of the control level. The polypeptide RIC6 
alone had no effect on the translocation capacity of the mem- 
brane (compare Fig.  3, lanes h and l). Moreover, neutral- 
ization of the anti-RIC6 antibody with the RIC6 peptide not 
only counteracted its ability to inhibit translocation but also 
its ability to inhibit translation. 
Monovalent Fab Fragments That Recognize a 
Cytoplasmic Segment of RI Inhibit Translocation 
The  capacity  of the  various  anti-RI  antibodies  to  inhibit 
translocation could be the direct result of their blocking a 
functional site within the cytoplasmic domain of the protein, 
or a consequence of a redistribution of microsomal proteins 
involved in translocation that results from antibody mediated 
cross-linking of ribophorin molecules that can be displaced 
within  the  fluid  microsomal  membrane  (Ojakian  et  al., 
1977). To determine whether cross-linking of RI was neces- 
sary  to  cause  an  inhibition of translocation,  the  effect of 
monovalent Fab fragments of the anti-RIC6 IgG was exam- 
ined. As is shown in Fig. 4, the Fab fragments also caused 
a marked inhibition of translocation (Fig. 4, lanes b, b'; 74 % 
inhibition), and this effect was also abolished by preincuba- 
tion  with  a  large  molar  excess  of the  synthetic  peptide, 
RIC6  (Fig.  4,  lanes  c,  c').  As  in  the previous cases,  the 
effect  of the antibody in translocation paralleled that in trans- 
lation. 
To determine whether binding of antibodies to a  micro- 
somal membrane protein that is not involved in translocation 
could inhibit translocation, the effect of polyclonal antibod- 
ies against a constitutive form of rat liver cytochrome P450 
(P450 2c) (Waxman, 1984) was examined using rat liver mi- 
crosomes. The concentration of this cytochrome in rat liver 
rough microsomes is at least as high as that of RI ('~1%) 
(Dannan et al.,  1983). Rat liver microsomes had to be used 
for this experiment since dog pancreas microsomes contain 
essentially no cytochrome P450 and no antibody against a 
dog pancreas membrane protein that is not involved in trans- 
location and present in sufficiently high concentration is known. 
As is the case with dog pancreas microsomes, anti-RIC6  an- 
tibodies inhibited protein translocation by rat liver micro- 
somes (compare Fig. 4, lanes d, d' withf, f; 89% inhibition), 
but the affinity-ptirified polyclonal anti-P450 2c antibodies 
had no effect (Fig. 4,  compare lanes d, d',  with e, e'). 
RI Antibodies Inhibit Translocation Only When Added 
before the Active Ribosomes Become Associated with 
the ER Membrane 
To obtain an insight into which step in the translocation pro- 
cess is blocked by anti-RI antibodies, the in vitro translation- 
translocation of GH was experimentally dissected into two 
stages.  In the first,  assembly, targeting and attachment of 
ribosome-nascent  chain-SRP  complexes  to  translocation 
sites in dog pancreas microsomes was allowed to take place 
during a very brief (3-rain) incubation period in the cell-free 
translation system. Protein synthesis was then halted by cool- 
ing on ice, and the microsomes, bearing ribosomes with ini- 
tiated, but incomplete chains, were recovered by centrifuga- 
tion. In the second stage, elongation of nascent chains that 
Figure 4. Monovalent Fab fragments of anti-RIC6 IgG inhibit pro- 
tein translocation. (A) Before addition to a translation mixture pro- 
grammed with GH mRNA, dog pancreas RMs (lanes a-c) or rat 
liver RMs (lanes d-f) were either kept untreated (lanes a and d) 
or  were  preincubated  with  afffinity-purified  anti-RIC6 antibody 
(lane f),  with the  Fab  fragment  of anti-RIC6 (lane b)  or with 
aflinity-purified anticytochrome P450 2c antibody (lane e).  In a 
control experiment, the RMs were preincnhated with the Fab frag- 
ments neutralized  by  preincnhation  with  RIC6 (C6) (lane  c). 
Duplicate samples were incubated with proteases (lanes a'-f') to 
assess the extent of translocation.  All samples were analyzed by 
SDS-PAGE and  autoradiography. The bands  with  the  mobility 
slightly higher than that of  GH do not represent translocated mature 
GH since the polypeptide is not protected from digestion by exoge- 
nous proteases. (B) Quantitative analysis of the autoradiograms. 
Footnotes 1-4 are defined in the legend to Fig.  1. 
* Determined from lanes d', e', and f'. 
were initiated during the 3-rain incubation period was al- 
lowed to take place in the presence of the inhibitor of initia- 
tion 7-methylguanosine-5-monophosphate (TmG(53p). It was 
demonstrated that, as expected, during the first brief incuba- 
tion, no completed preGH or mature GH molecules were 
synthesized (Fig. 5, lane e). However, the synthesis of preGH 
molecules was initiated during this period and a substantial 
Yu et al.  Ribophorins  Are Involved in Protein Translocation  1339 Figure 5. Protein translocation is inhibited only when antibodies are 
added before translocation  is initiated.  Dog pancreas RMs prein- 
cubated  with  (lane  b)  or without  (lane  a)  afffinity-purified  anti- 
RIC6 antibody were incubated in a translation mixture containing 
growth hormone mRNA for 3 rain to allow initiation  of preGH 
polypeptides and targeting of active ribosomes to the microsomal 
membranes.  The microsomes  were then recovered by centrifuga- 
tion and resuspended in a translation mixture with no added mRNA, 
hut containing  the  inhibitor  of translational  initiation  7mG(5')p. 
After elongation was allowed to proceed for 90 min, the extent of 
synthesis and translocation  was assessed by electrophoresis  with 
(a', b'), or without (a, b) previous incubation with proteases.  In 
other samples (c, d), untreated  RMs were incubated for 3 min in 
the translation mixture to allow initiation and targeting, the micro° 
somes were then recovered by centrifugation  and resuspended  in 
PBS alone  (lane c) or PBS containing  affinity-purified anti-RIC6 
antibody (lane d). After the incubation, the RMs were once again 
recovered by centrifugation,  washed, and incubated for 90 min to 
allow for elongation of nascent chains. The supernatants obtained 
after the  3-min incubation  from both  types of experiments  were 
used to assess the extent of translation that takes place during that 
brief incubation and the amount of initiated preGH chains present 
in ribosomes that did not bind to the membranes. The supernatants 
were split into two aliquots, one of which was analyzed directly (e, 
e'), and the other after further incubation for 90 min in the presence 
of the inhibitor of initiation (f f'). Since the results obtained from 
all four supernatants  were indistinguishable,  only one  set of au- 
toradiographs  is shown. Duplicate  samples  were incubated  with 
proteases  (a'-f')  to assess the extent of translocation. 
number  of ribosomes bearing  nascent  chains  became as- 
sociated with translocation sites on the microsomal mem- 
branes  and  were,  thus,  recovered  with  the  sedimentable 
microsomes.  Thus,  during  the  second  incubation,  large 
numbers of completed polypeptides, mostly mature GH mol- 
ecules, were produced and these were resistant to the attack 
of added proteases, which indicates that they had been trans- 
located into the microsomal lumen (Fig.  5, lanes a  and a3. 
The fact that only very small amounts (varying slightly in 
different experiments) of preGH were produced during the 
second incubation indicates that almost all the active ribo- 
somes that had become attached to the membrane during the 
preincubation were associated with functional translocation 
sites. As expected,  elongation of the unattached chains as- 
sociated  with  ribosomes that  remained unbound  after the 
first incubation  resulted  only in  protease-sensitive preGH 
(Fig.  5,  lanes f  and f). 
When  RMs  pretreated  with  an  antibody  (anti-RIC6)  to 
the cytoplasmic domain of RI were used for these experi- 
ments,  essentially  no  initiation  complexes were recovered 
with the sedimentable microsomes after the first incubation, 
since no completed preGH or GH polypeptides were detected 
after the second incubation (Fig. 5, lanes b and b'). This sug- 
gests that the binding of antibodies to RI prevents the assem- 
bly of ribosome-nascent chain complexes on membrane trans- 
location sites. It cannot be excluded, however, that targeting 
of active ribosomes to the membrane took place during the 
first incubation, but the antibody, in blocking translocation, 
also blocked further elongation of the nascent chains. 
In a complementary experiment, the microsomes were in- 
cubated with the anti-RI antibodies only after targeting and 
assembly had been allowed to occur during the first 3 min 
of incubation. Analysis of these samples showed that, in this 
case,  completion of the synthesis and translocation of GH 
polypeptides in ribosomes, which became attached during 
the first incubation,  were unaffected by the treatment with 
antibodies (Fig. 5, lanes c and c', d and d'). The possibility 
that preincubation in the translation mixture itself, indepen- 
dentl]¢ of protein synthesis, rendered the microsomes resistant 
to the antibody inhibition, perhaps by blocking the binding 
of the antibodies,  was ruled out,  since microsomes prein- 
cubated in a  translation  mixture lacking mRNA remained 
sensitive to antibody inhibition (data not shown). One must 
conclude, therefore, that RI plays a role in the initial target- 
ing assembly step of protein translocation in the ER. RI may 
also be involved in the actual transfer of the nascent chain 
across the membrane, but,  if this is the case, the failure of 
the  antibodies  to  inhibit  translocation  after  ribosome- 
membrane junctions had been formed may reflect the inac- 
cessibility of the cytoplasmic domain of RI to the antibodies 
or that, after translocation has begun, binding of antibodies 
to its cytoplasmic domain does not interfere with its continu- 
ing role in this translocation process. 
Discussion 
The results just presented demonstrate that antibodies to ei- 
ther RI or RII abolished the capacity of rough microsomal 
membranes to effect the signal sequence-mediated cotransla- 
tional translocation of a polypeptide into the microsomal lu- 
men. Using antibodies directed against specific sites within 
the RI primary sequence, it was shown that this effect is the 
direct result of the specific interaction of the antibodies with 
epitopes located within the cytoplasmic domain of the protein. 
Ribophorins are known to be part of an extensive protein 
network within the  ER membrane that links the  ribosome 
binding sites to each other, and it has been shown that this 
network  can  undergo  extensive  displacement  within  the 
plane of the membrane (Ojakian et al.,  1977).  This is the 
case, for example, when the aggregation of bound ribosomes 
is induced by incubating the microsomes with low concen- 
trations of detergents  (Kreibich et al.,  1982),  with ribonu- 
clease, or with antibodies to ribosomal proteins (Ojakian et 
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microsomal proteins are collected with the aggregated ribo- 
somes in limited regions of the microsomal membrane. The 
ability of the ribophorins to form aggregates within the plane 
of the membrane is also manifested when microsomal mem- 
branes are solubilized with certain nonionic detergents. Af- 
ter this treatment, the ribosomes are recovered on cup-shaped 
membrane remnants that still contain ribophorins in amounts 
approximately equimolar with the bound ribosomes (Kreibich 
et al., 1978a).  The possibility that the antibodies, by cross- 
linking ribophorin molecules, simply interfered with trans- 
location by nonspecifically disturbing the spatial arrangement 
in the membrane of other proteins that participate directly 
in this process was, however, eliminated by the finding that 
monovalent Fab fragments of  the antipeptide antibodies to RI 
were as effective as the intact antibody molecules in blocking 
translocation. Moreover,  bivalent polyclonal antibodies to 
cytochrome P450,  which are also capable of cross-linking 
microsomal proteins, had no effect on translocation. 
Ribophorins constitute <1%  of the total protein  in the 
microsomal  membrane  (Marcantonio  et  al.,  1984),  and 
saturating amounts of anti-ribophorin Fab fragments, which 
are less than one-third the size of intact IgG molecules, could 
only cover a very small fraction of the microsomal surface. 
Hence, the efficacy of the Fab fragments in inhibiting trans- 
location provides strong evidence for a close physical associ- 
ation of the ribophorins with the sites of translocation in the 
ER membrane, as would be expected if ribophorins partici- 
pate directly in this process. The findings that the antibodies 
did not inhibit translocation when they were added as early 
as 3 rain after the start of translational initiation, and that 
they,  in fact prevented the association of the SRP-nascent 
chain-ribosome-mRNA complexes with the membrane that 
normally takes place during that brief interval, would sug- 
gest that ribophorins are involved in steps within the target- 
ing phase of translocation. This possibility is supported by 
the observation that the inhibition of translocation caused by 
the preincubation of RMs with antibodies was consistently 
accompanied by a reduction in the total translational yield, 
ranging from 30% to 60% and that antibodies that did not 
inhibit translocation, or had been blocked with competing 
antigen, did not inhibit total translation. This would be the 
expected outcome if the antibodies prevent the SRP receptor 
in the membrane from releasing the SRP-mediated elonga- 
tion arrest of pre-GH.  A  similar observation has recently 
been made with an antibody directed against the putative sig- 
nal sequence receptor (SSR)  (Hartman et ah,  1989). 
The failure of the antibodies to inhibit translocation when 
added  after  the  ribosome-membrane junction  had  been 
formed does not preclude that ribophorins actually play a 
role in posttargeting steps of translocation, such as the pas- 
sage of the polypeptide through the membrane or its cotrans- 
lational modification. In fact, it is possible that the ribopho- 
rins only play a role in the late stages of translocation and 
that the antibodies to their cytoplasmic domains inhibited the 
targeting phase by stericaUy hindering the function of other 
proteins involved in targeting. The antibodies, however, may 
not be  able  to perturb  the  intrinsic  late  functions of the 
ribophorins because these  involve  directly the transmem- 
brane or luminal domains of  the proteins. Alternatively, after 
the ribosome-membrane junction is formed, the antibodies 
may no longer have access to the ribophorins if the cytoplas- 
mic domains of these proteins, for example, become covered 
by the ribosome that attaches to the membrane. 
Previous  studies have shown that only a  small fraction 
(<1%) of the total number of ribosome binding sites on the 
surface of rough microsomal membranes is actually capable 
of participating in the translocation of nascent polypeptides 
in in vitro systems (Walter and Blobel, 1980; Kreibich et al., 
1981). In fact, although stripping of ribosomes from RMs 
markedly increases the capacity of the membranes to bind 
ribosomes (Borgese et al., 1974), it does not significantly  in- 
crease the number of translocation sites  (Kreibich et ah, 
1981; Walter and Blobel,  1983)  that is reflected by the in 
vitro translocation capacity of the membranes. Our finding 
that essentially all the mRNA-ribosome-nascent chain com- 
plexes that after a brief initiation period become associated 
with the membranes successfully completed translocation in a 
second incubation indicates that,  under the conditions of 
protein synthesis in which this association takes place, active 
ribosomes that contain mRNA only bind to those ribosome 
binding sites that are capable of translocation. This indicates 
that, physiologically, ribosome binding only takes place if 
signal-mediated targeting has occurred. Since the SRP re- 
ceptor, which plays an essential role in targeting, is known 
to be present in quantities substantially below the number of 
ribosome binding sites (Tajima et al., 1986), the association 
of this receptor with a ribosome binding site may have been 
the factor that determined whether the site was functional in 
targeting during the first 3 min incubation and could, there- 
fore, carry out the complete translocation process. Indeed, 
as suggested above, the effect of the antiribophorin antibod- 
ies in inhibiting targeting may have been due to their block- 
ing the interaction between SRP and its receptor, a possibil- 
ity that is now being tested experimentally. 
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